HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:DOC - US42250P1030 - REIT
16.81 USD
+0.1 (+0.6%)
17.04 USD
+0.23 (+1.37%)
Taking everything into account, DOC scores 3 out of 10 in our fundamental rating. DOC was compared to 126 industry peers in the Diversified REITs industry. While DOC is still in line with the averages on profitability rating, there are concerns on its financial health. DOC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
DOC had positive earnings in the past year.
DOC had a positive operating cash flow in the past year.
Each year in the past 5 years DOC has been profitable.
DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DOC's Return On Assets of -0.20% is on the low side compared to the rest of the industry. DOC is outperformed by 61.11% of its industry peers.
Looking at the Return On Equity, with a value of -0.51%, DOC is doing worse than 61.11% of the companies in the same industry.
With a Return On Invested Capital value of 2.23%, DOC perfoms like the industry average, outperforming 42.06% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.06%.
The last Return On Invested Capital (2.23%) for DOC is above the 3 year average (2.19%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROIC | 2.23% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
1.3 Margins
In the last couple of years the Profit Margin of DOC has grown nicely.
DOC has a Operating Margin (18.19%) which is in line with its industry peers.
DOC's Operating Margin has declined in the last couple of years.
DOC has a worse Gross Margin (60.08%) than 67.46% of its industry peers.
DOC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% |
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DOC is destroying value.
Compared to 1 year ago, DOC has more shares outstanding
The number of shares outstanding for DOC has been increased compared to 5 years ago.
Compared to 1 year ago, DOC has about the same debt to assets ratio.
2.2 Solvency
DOC has an Altman-Z score of 0.31. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.31, DOC is not doing good in the industry: 62.70% of the companies in the same industry are doing better.
The Debt to FCF ratio of DOC is 20.30, which is on the high side as it means it would take DOC, 20.30 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DOC (20.30) is better than 76.98% of its industry peers.
DOC has a Debt/Equity ratio of 1.20. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.20, DOC is in line with its industry, outperforming 54.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Altman-Z | 0.31 |
ROIC/WACC0.35
WACC6.3%
2.3 Liquidity
A Current Ratio of 0.11 indicates that DOC may have some problems paying its short term obligations.
The Current ratio of DOC (0.11) is worse than 95.24% of its industry peers.
A Quick Ratio of 0.11 indicates that DOC may have some problems paying its short term obligations.
DOC has a Quick ratio of 0.11. This is amonst the worse of the industry: DOC underperforms 95.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 |
3. Growth
3.1 Past
The earnings per share for DOC have decreased strongly by -57.45% in the last year.
The Earnings Per Share has been growing by 28.47% on average over the past years. This is a very strong growth
DOC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.58%.
DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.84% yearly.
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
3.2 Future
The Earnings Per Share is expected to decrease by -0.97% on average over the next years.
Based on estimates for the next years, DOC will show a small growth in Revenue. The Revenue will grow by 4.64% on average per year.
EPS Next Y-34.04%
EPS Next 2Y-12.64%
EPS Next 3Y-7.34%
EPS Next 5Y-0.97%
Revenue Next Year3.67%
Revenue Next 2Y2.91%
Revenue Next 3Y3.41%
Revenue Next 5Y4.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 84.05, the valuation of DOC can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as DOC.
When comparing the Price/Earnings ratio of DOC to the average of the S&P500 Index (27.25), we can say DOC is valued expensively.
The Price/Forward Earnings ratio is 62.94, which means the current valuation is very expensive for DOC.
DOC's Price/Forward Earnings ratio is in line with the industry average.
DOC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 84.05 | ||
| Fwd PE | 62.94 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DOC is valued a bit cheaper than 65.08% of the companies in the same industry.
DOC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DOC is cheaper than 73.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.97 | ||
| EV/EBITDA | 13.07 |
4.3 Compensation for Growth
A cheap valuation may be justified as DOC's earnings are expected to decrease with -7.34% in the coming years.
PEG (NY)N/A
PEG (5Y)2.95
EPS Next 2Y-12.64%
EPS Next 3Y-7.34%
5. Dividend
5.1 Amount
DOC has a Yearly Dividend Yield of 7.16%, which is a nice return.
DOC's Dividend Yield is a higher than the industry average which is at 6.86.
Compared to an average S&P500 Dividend Yield of 1.92, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.16% |
5.2 History
The dividend of DOC decreases each year by -2.76%.
DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DOC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DOC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-2176.08%
EPS Next 2Y-12.64%
EPS Next 3Y-7.34%
16.81
+0.1 (+0.6%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners97.22%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change0.78%
Market Cap11.68B
Revenue(TTM)2.80B
Net Income(TTM)-38.93M
Analysts75.83
Price Target20.7 (23.14%)
Short Float %3.18%
Short Ratio2.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.16% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP-2176.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.17%
Min EPS beat(2)-19.41%
Max EPS beat(2)37.75%
EPS beat(4)2
Avg EPS beat(4)-12.11%
Min EPS beat(4)-79.16%
Max EPS beat(4)37.75%
EPS beat(8)5
Avg EPS beat(8)12.39%
EPS beat(12)7
Avg EPS beat(12)15.73%
EPS beat(16)10
Avg EPS beat(16)43.13%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)0.74%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)8
Avg Revenue beat(12)-4.75%
Revenue beat(16)11
Avg Revenue beat(16)-3.38%
PT rev (1m)-1.15%
PT rev (3m)-3.67%
EPS NQ rev (1m)-2.74%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.69%
Revenue NQ rev (1m)-0.23%
Revenue NQ rev (3m)-0.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 84.05 | ||
| Fwd PE | 62.94 | ||
| P/S | 4.17 | ||
| P/FCF | 25.97 | ||
| P/OCF | 9.41 | ||
| P/B | 1.54 | ||
| P/tB | 1.67 | ||
| EV/EBITDA | 13.07 |
EPS(TTM)0.2
EY1.19%
EPS(NY)0.27
Fwd EY1.59%
FCF(TTM)0.65
FCFY3.85%
OCF(TTM)1.79
OCFY10.62%
SpS4.03
BVpS10.93
TBVpS10.05
PEG (NY)N/A
PEG (5Y)2.95
Graham Number7.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROCE | 2.83% | ||
| ROIC | 2.23% | ||
| ROICexc | 2.25% | ||
| ROICexgc | 2.46% | ||
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% | ||
| FCFM | 16.06% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexgc growth 3Y3.4%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score4
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Debt/EBITDA | 5.78 | ||
| Cap/Depr | 73.87% | ||
| Cap/Sales | 28.24% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 78.53% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 | ||
| Altman-Z | 0.31 |
F-Score4
WACC6.3%
ROIC/WACC0.35
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
EPS Next Y-34.04%
EPS Next 2Y-12.64%
EPS Next 3Y-7.34%
EPS Next 5Y-0.97%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
Revenue Next Year3.67%
Revenue Next 2Y2.91%
Revenue Next 3Y3.41%
Revenue Next 5Y4.64%
EBIT growth 1Y-12.91%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year226.81%
EBIT Next 3Y51.61%
EBIT Next 5Y31.86%
FCF growth 1Y542.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.14%
OCF growth 3Y10.42%
OCF growth 5Y4.82%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 4 / 10.
What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 84.05 and the Price/Book (PB) ratio is 1.54.
How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is -2176.08%.